Xtant Medical Inks Exclusive Dental Deal with BioHorizons

Event summary

Xtant Medical has partnered exclusively with BioHorizons to distribute its allogeneic growth factor technology, Prolifica™, in the U.S. and Canadian dental markets.
BioHorizons will private brand the technology as Prolifica™ and leverage its commercial network to expand access.
The partnership combines Xtant's regenerative medicine expertise with BioHorizons' established customer relationships.
Prolifica™ is designed to support bone healing and regeneration across various clinical applications.

The big picture

This partnership marks Xtant Medical's strategic push into the dental market, leveraging BioHorizons' established commercial infrastructure. The deal underscores the growing importance of regenerative medicine in dental procedures, as well as the trend of medical technology companies expanding into adjacent healthcare sectors. The collaboration could set a precedent for similar partnerships in the orthobiologics space.

What we're watching

Market Penetration: How quickly Prolifica™ gains acceptance among dental clinicians through BioHorizons' network.
Revenue Impact: Whether the partnership can drive significant revenue growth for Xtant Medical in the dental sector.
Long-term Collaboration: The pace at which the strategic relationship between Xtant and BioHorizons deepens beyond this initial agreement.